MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.
about
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysisNew and emerging immune-targeted drugs for the treatment of multiple sclerosisCentral Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.Gray matters in multiple sclerosis: cognitive impairment and structural MRI.Depressive symptoms in multiple sclerosis from an in vivo study with TBSS.Progressive multiple sclerosis and gray matter pathology: an MRI perspective.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.Sex differences and subclinical retinal injury in pediatric-onset MS.Paroxysmal dystonia as a rare initial manifestation of multiple sclerosis.Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.
P2860
Q26824991-6B54634A-447A-4B23-AE2A-087DC94AF46BQ26997067-CAFC2A40-7006-40DF-970A-288C90537A14Q30395772-EE4274A9-83BF-46D9-9A19-939FD9520873Q30768942-A80241BC-9F9D-4EE3-A731-25C5F940F541Q33625308-17770252-81AB-4DAD-B2F9-CEE832C361A9Q33852170-76928C89-120D-4F72-A389-F6B3B05CC550Q35059951-954470FC-5F34-426C-A5CE-93F445857D1DQ35990016-A761E403-F8F3-47D7-A534-1AA93DAEC6F1Q36211674-72103626-6CBA-4A05-9F48-2256EBCA7F5CQ36475759-D59785B5-96FA-4944-9B4F-4BD1EF758ED0Q37048758-0A3233F0-9255-4BD2-93FA-83D977440B09Q37296089-FE899121-B30D-4346-90FF-182625BD2C93Q40338918-452F462B-0D09-4816-A56F-61E029F37FF6Q44915739-9BDC6647-9CEE-4ADA-AFB2-2E8ED22C6AC4Q48352042-B4085594-EABA-471F-A935-F58BA3862CDEQ48403694-F1A160B7-9EAD-4EAE-89C4-6AE5512F1560Q50225781-D873EF03-FF2F-4A3F-AA9D-A31ED26C2A36Q50263831-092BDDE6-DD07-4413-89C9-AB676A2E4770Q55397967-FC7D160D-A229-418F-BD23-89DBF00B5DAC
P2860
MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@ast
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@en
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@nl
type
label
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@ast
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@en
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@nl
prefLabel
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@ast
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@en
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@nl
P2860
P356
P1476
MR imaging of gray matter invo ...... monitoring treatment efficacy.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A1944
P577
2009-12-31T00:00:00Z